These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 20202594

  • 21. B cell depletion therapy in systemic lupus erythematosus.
    Anolik J, Sanz I, Looney RJ.
    Curr Rheumatol Rep; 2003 Oct; 5(5):350-6. PubMed ID: 12967516
    [Abstract] [Full Text] [Related]

  • 22. [Progress in B-cell targeting therapy for the treatment of systemic lupus erythematosus].
    Tanaka Y.
    J UOEH; 2011 Jun 01; 33(2):173-81. PubMed ID: 21702122
    [Abstract] [Full Text] [Related]

  • 23. Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus?
    Gorman C, Leandro M, Isenberg D.
    Lupus; 2004 Jun 01; 13(5):312-6. PubMed ID: 15230284
    [Abstract] [Full Text] [Related]

  • 24. SLE - Rituximab in lupus.
    Eisenberg R.
    Arthritis Res Ther; 2003 Jun 01; 5(4):157-9. PubMed ID: 12823844
    [Abstract] [Full Text] [Related]

  • 25. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T.
    J Rheumatol Suppl; 2006 May 01; 77():3-11. PubMed ID: 16652439
    [Abstract] [Full Text] [Related]

  • 26. Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future.
    Sfikakis PP, Boletis JN, Tsokos GC.
    Curr Opin Rheumatol; 2005 Sep 01; 17(5):550-7. PubMed ID: 16093832
    [Abstract] [Full Text] [Related]

  • 27. Monoclonal antibodies in the treatment of systemic lupus erythematosus.
    Robak E, Robak T.
    Curr Drug Targets; 2009 Jan 01; 10(1):26-37. PubMed ID: 19149533
    [Abstract] [Full Text] [Related]

  • 28. B-cell depletion and repopulation in autoimmune diseases.
    Pers JO, Daridon C, Bendaoud B, Devauchelle V, Berthou C, Saraux A, Youinou P.
    Clin Rev Allergy Immunol; 2008 Feb 01; 34(1):50-5. PubMed ID: 18270858
    [Abstract] [Full Text] [Related]

  • 29. Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
    Kotani T, Takeuchi T, Kawasaki Y, Hirano S, Tabushi Y, Kagitani M, Makino S, Hanafusa T.
    Lupus; 2006 Feb 01; 15(10):683-5. PubMed ID: 17120596
    [Abstract] [Full Text] [Related]

  • 30. Rituximab and lupus--a promising pair?
    Ekö SL, van Vollenhoven RF.
    Curr Rheumatol Rep; 2014 Feb 01; 16(9):444. PubMed ID: 25074032
    [Abstract] [Full Text] [Related]

  • 31. B-cell-targeted therapy for systemic lupus erythematosus: an update.
    Ding C, Foote S, Jones G.
    BioDrugs; 2008 Feb 01; 22(4):239-49. PubMed ID: 18611066
    [Abstract] [Full Text] [Related]

  • 32. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
    Tokunaga M, Fujii K, Saito K, Nakayamada S, Tsujimura S, Nawata M, Tanaka Y.
    Rheumatology (Oxford); 2005 Feb 01; 44(2):176-82. PubMed ID: 15494350
    [Abstract] [Full Text] [Related]

  • 33. Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus.
    Shah K, Cragg M, Leandro M, Reddy V.
    Biologicals; 2021 Jan 01; 69():1-14. PubMed ID: 33288390
    [Abstract] [Full Text] [Related]

  • 34. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A.
    Nihon Rinsho Meneki Gakkai Kaishi; 2016 Jan 01; 39(3):197-206. PubMed ID: 27320935
    [Abstract] [Full Text] [Related]

  • 35. Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus.
    Faria RM, Isenberg DA.
    Lupus; 2010 Sep 01; 19(10):1256-7. PubMed ID: 20534646
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
    Merrill JT, Neuwelt CM, Wallace DJ, Shanahan JC, Latinis KM, Oates JC, Utset TO, Gordon C, Isenberg DA, Hsieh HJ, Zhang D, Brunetta PG.
    Arthritis Rheum; 2010 Jan 01; 62(1):222-33. PubMed ID: 20039413
    [Abstract] [Full Text] [Related]

  • 37. B cells biology in systemic lupus erythematosus-from bench to bedside.
    Zhao L, Ye Y, Zhang X.
    Sci China Life Sci; 2015 Nov 01; 58(11):1111-25. PubMed ID: 26563177
    [Abstract] [Full Text] [Related]

  • 38. B cell-targeted therapies for systemic lupus erythematosus: an update on clinical trial data.
    Looney RJ.
    Drugs; 2010 Mar 26; 70(5):529-40. PubMed ID: 20297867
    [Abstract] [Full Text] [Related]

  • 39. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG, Richey LJ, Bolland S, Mehta AJ, Kearney JF, Huber BT.
    Autophagy; 2015 Mar 26; 11(7):1010-24. PubMed ID: 26120731
    [Abstract] [Full Text] [Related]

  • 40. [Anti-CD20 antibody therapy for inflammatory immune diseases].
    Tanaka Y.
    Nihon Naika Gakkai Zasshi; 2006 Sep 10; 95(9):1801-6. PubMed ID: 17037318
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.